Skip to content

Investigating the Efficacy of Human Dental Pulp Stem Cells on Outcomes in Patients with Traumatic Brain Injury

Investigating the Efficacy of Human Dental Pulp Stem Cells on Outcomes in Patients with Traumatic Brain Injury

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250627066269N1
Enrollment
14
Registered
2025-07-11
Start date
2025-07-08
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury. Diffuse traumatic brain injury

Interventions

Intervention 1: Intervention group: Patients in this group will receive intra-carotid injections of allogeneic human dental pulp stem cells (hDPSCs) at a dose of 1 million cells/kg body weight in four

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Severe traumatic brain injury with a Glasgow Coma Scale score between 5 and 7 Age between 18 and 70 years Non-penetrating TBI Trauma occurred less than 72 hours before obtaining consent TBI confirmed by CT scan (Marshall score >1) At least one reactive pupil present

Exclusion criteria

Exclusion criteria: Serious comorbidities or prior infections revealed by the patient’s medical history Previous moderate to severe brain injury Major psychiatric disorders Any neurological disorder or prior seizures requiring anticonvulsant therapy Evidence of prolonged hypoxic exposure Intracranial Pressure (ICP) greater than 40 mmHg on admission Hemodynamic instability despite continued fluid resuscitation and/or inotropic support Bilateral non-reactive mydriasis Unstable pelvic fracture requiring surgical fixation Spinal cord injury Positive urine pregnancy test Grade IV intra-abdominal injury (AAST classification) Weight of 130 kg or more Positive urine drug screen on admission Contraindications to MRI present

Design outcomes

Primary

MeasureTime frame
Treatment effectiveness. Timepoint: One week, One month, 6 months after intervention. Method of measurement: Glasgow Outcome Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Hojati

Kerman University of Medical Sciences

Ali.hojati1993@yahoo.com+98 34 3226 5433

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026